Relmada Therapeutics
RLMD
RLMD
94 hedge funds and large institutions have $39.6M invested in Relmada Therapeutics in 2023 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 23 increasing their positions, 35 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
34% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 35
81% less call options, than puts
Call options by funds: $271K | Put options by funds: $1.4M
Holders
94
Holding in Top 10
–
Calls
$271K
Puts
$1.4M
Top Buyers
| 1 | +$514K | |
| 2 | +$491K | |
| 3 | +$477K | |
| 4 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$468K |
| 5 |
PCM
Parsons Capital Management
Providence,
Rhode Island
|
+$372K |
Top Sellers
| 1 | -$3.03M | |
| 2 | -$1.04M | |
| 3 | -$659K | |
| 4 |
Walleye Capital
New York
|
-$593K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$480K |